Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study

Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study

Abstract Background Nephrotoxicity and ototoxicity are clinically significant dose-related adverse effects associated with second-line anti-tubercular injectables drugs (aminoglycosides and capreomycin) used during intensive phase of treatment of multi-drug resistant tuberculosis (MDR-TB) patients....

Full description

Bibliographic Details
Main Authors: Workineh Shibeshi, Anandi N. Sheth, Addisu Admasu, Alemseged Beyene Berha, Zenebe Negash, Getnet Yimer
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Pharmacology and Toxicology
Subjects:
Nephrotoxicity
Ototoxicity
MDR-TB
Injectables
Online Access:http://link.springer.com/article/10.1186/s40360-019-0313-y

Internet

http://link.springer.com/article/10.1186/s40360-019-0313-y

Similar Items